Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since the start of the …

Neuropsychiatric manifestations of coronavirus disease 2019 (COVID-19) have been
increasingly recognized. However, the pathophysiology of COVID-19 in the central nervous …

Background Long COVID-19 syndrome is a complex of symptoms that occurs after the acute
SARS-CoV-2 infection, in the absence of other possible diagnoses. Studies on Long COVID …

Olfactory dysfunction related to SARS-CoV-2 infection and COVID-19 disease is now well
established in the literature. In December 2020, the FDA approved the Pfizer-BioNTech and …

Background Many patients with coronavirus disease 2019 (COVID-19) complain from
olfactory dysfunction (OD). Aims/objectives: To evaluate the prevalence, prognosis, and …

The recent pandemic of the coronavirus infectious disease 2019 (COVID‑19) has affected
around 192 countries, and projections have shown that around 40% to 70% of world …

Although initially the evolution of Coronavirus disease 2019 (COVID-19) seemed less
severe in pediatric patients, in the three years since the beginning of the pandemics, several …

Objective The scientific community knows little about the long-term influence of coronavirus
disease 2019 (COVID-19) on olfactory dysfunction (OD). With the COVID-19 pandemic …

Das Virus SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus Type 2) und die
von ihm ausgelöste Erkrankung COVID-19 (Coronavirus Disease 2019) können zahlreiche …

Background: Many patients with Coronavirus disease 2019 (COVID-19) complain from
olfactory dysfunction (OD). This study aims to evaluate the prevalence, prognosis, and …